TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
拉维·S。
2 个月前
Sneha T.
1 个月前
苏雷什· K.
4天前
Ayesha M.
5天前
